Partial hepatectomy reduces the endotoxin-induced peak circulating level of tumor necrosis factor in rats

Shock

Volumn 5, Issue 5, 1996, Pages 385-388

  Kumins, Norman H ^a   Hunt, Julia ^b   Gamelli, Richard L ^b   Filkins, James P ^b,c  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^c LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; LIVER; LIVER RESECTION; MALE; METABOLISM; PATHOLOGY; RAT; SEPTIC SHOCK;

ANIMALS; ENDOTOXINS; HEPATECTOMY; LIVER; MALE; RATS; SHOCK, SEPTIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030133341     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199605000-00012     Document Type: Article

References (29)

1. Increase in National Hospital Discharge Survey rates for septicemia-United States, 1979-1987. MMWR Morb Mortal Wkly Rep 39:31-34, 1979.
2. Centers for Disease Control MMWR 39:31-34, 1990.
3. Bone RC, Fisher CJ Jr, Clemmer TP, Slotman GJ, Metz CA, Balk RA: A controlled trial of high-dose methylprednisone in the treatment of severe sepsis and septic shock. N Engl J Med 317:653-658, 1987.
4. The Veterans Administration Systemic Sepsis Cooperative Study Group: N Engl J Med 317:659-665, 1987.
5. Waage A, Shalaby R, Espivik T: Tumor necrosis factor, interleukin-1, interleukin-6, interleukin-8, and interferon gamma in septic shock. In Kunkel SL, Remick DH (eds): Cytokines in Health and Disease. New York: Marcel Dekker, Inc., 1992, pp 151-164.
6. Hesse DG, Tracey KJ, Fong Y, et al: Cytokine appearance in human endotoxemia and primate bacteremia. Surg Gynecol Obstet 166:147-153, 1988.
7. Michie HR, Manogue KR, Spriggs DR, et al: Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 318:1481-1486, 1988.
8. Fong Y, Marano MA, Moldawer LL, et al: Acute splanchnic and peripheral tissue metabolic response to endotoxin in humans. J Clin Invest 85:1896-1904, 1990.
9. Cannon JG, Thompkins RG, Gelfand JA, et al: Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J Infect Dis 161:79-84, 1990.
10. Evans GF, Snyder YM, Butler LD, Zuckerman SH: Differential expression of interleukin-1 and tumor necrosis factor in murine septic shock models. Circ Shock 29:279-290, 1989.
11. Waage A: Production and clearance of tumor necrosis factor in rats exposed to endotoxin and dexamethasone Clin Immunol Immunopathol 45:348-355, 1987.
12. Bagby GJ, Corll CB, Thompson JJ, Wilson LA: Lipoprotein lipase-suppressing mediator in serum of endotoxin-treated rats. Am J Physiol 251:E470-E476, 1986.
13. Cannon JG: Bacterial Endotoxic Lipopolysaccharides, vol. II. Ryan JL, Morrison DC (eds), Boca Raton, FL, 1992, pp 311-326.
14. Cross AS, Opal SM, Sadoff JC, Gemski P: Choice of bacteria in animal models of sepsis. Infect Immunol 61:2741-2747, 1993.
15. Tracey KJ, Fong Y, Hesse DG, et al: Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteremia. Nature 330:662-664, 1987.
16. Beutler B, Milsark IW, Cerami AC: Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin Science 229:869-871, 1985.
17. Tracey KJ, Beutler B, Lowry SF, et al: Shock and tissue injury induced by recombinant human cachectin. Science 234:470-474, 1986.
18. Tracey KJ, Lowry SF, Fahey TJ, et al: Cachectin/tumor necrosis factor induces lethal shock and stress hormone response in the dog. Surg Gynecol Obstet 164:415-422, 1987.
19. Hesse D, Davatelis G, Felsen D, et al: Cachetin/tumor necrosis factor gene expression in Kupffer cells. J Leukocyte Biol 42:422, 1987.
20. Beutler B, Krochin N, Milsark IW, Luedke C, Cerami A: Control of cachectin (tumor necrosis factor) synthesis: Mechanism of endotoxin resistance. Science 232:977-980, 1986.
21. Gallery MP, Kamei T, Mangino MJ, Flye MW: Organ interactions in sepsis: Host defense and the hepatic-pulmonary macrophage axis. Arch Surg 126:28-32, 1991.
22. Braude AI, Carey FG, Zalesky N: Studies with radioactive endotoxin II: Correlation of physiologic effects with distribution of radioactivity in rabbits infected with lethal doses of E. coli endotoxin labeled with radioactive sodium chromate. J Clin Invest 34:858-866, 1955.
23. Higgins GM, Anderson RM: Experimental pathology of the liver: Restoration of liver of the white rat following partial surgical removal. Arch Pathol 12:186-202, 1931.
24. Minuk G, Gauther T, Benarroch A: Changes in serum and hepatic polyamine concentrations after 30%, 70% and 90% partial hepatectomy in rats. Hepatology 12:542-546, 1990.
25. Gaub J, Iverson J: Rat liver regeneration after 90% partial hepatectomy. Hepatology 4:902-904, 1984.
26. Decker T, Lohmann-Matthes ML, Karck U, Peters T, Decker K: Comparative study of cytotoxicity, tumor necrosis factor, and prostaglandin release after stimulation of rat Kupffer cells, murine Kupffer cells, and murine inflammatory liver macrophages. J Leukocyte Biol 45:139-146, 1989.
27. Bautista AP, Skrepnik N, Niesman MR, Bagby GJ: Elimination of a subpopulation of Kupffer cells by liposome-encapsulated dichloromethylene diphosphonate suppresses the endotoxin-induced activation of hepatic macrophages. In Knook DL, Wisse E (eds): Cells of the Hepatic Sinusoid, vol. 4. AK Leiden, The Netherlands: Kupffer Cell Foundation, 1993, pp 48-50.
28. Bagby GJ, Ejiofor J, McGuiness OP: The liver is a site of tumor necrosis factor release following acute intraportal endotoxin infusion. Shock 3:(Suppl)A1, 1995.
29. Decker KF, Obdenskaya MY: Cytokines, nitric oxide synthesis and liver regeneration. J Gastrol Hepatol 10:512-517, 1995.